Clinical Trial Update: Quetiapine Treatment for Pediatric Delirium [Phase 2, Phase 3]

View source ↗

Summary

A pediatric delirium trial evaluating quetiapine was withdrawn after phases 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Delirium | Phase 2, Phase 3 | Status: WITHDRAWN